AHN-GOOK PHARMACEUTICAL Co., Ltd. Gwacheon office property acquisition for KRW 163.0 billion
AI summary · Not investment advice
AHN-GOOK PHARMACEUTICAL Co., Ltd. will acquire land and an office building in a Gwacheon special planning zone for KRW 163.0 billion, 52.42% of total assets.
Acquisition amount
KRW 163.0 billion
52.42% of total assets · estimated price, settled after completion
Key facts
- Asset
- Office facility, Special Planning Zone 3, Gwacheon public housing district (land 3,737.95㎡, building 33,058㎡)
- % of total assets
- 52.42%
- Counterparty
- Medi Park 1 PFV Co.,LtdShares officers or employees with the company
- Asset type
- Land and building
- Board resolution date
- Oct 15, 2026
Commentary
AI commentary · Not investment advice
What happened
Ahn-Gook Pharmaceutical will acquire an office building to be constructed in Gwacheon, Gyeonggi-do, together with its land. The property is in Special Planning Zone 3 of the Gwacheon public housing district, with 3,737.95㎡ of land and 33,058㎡ of floor space. The price is KRW 163.0 billion. The seller is the developer, Medi Park 1 PFV Co.,Ltd, which shares officers or employees with Ahn-Gook. The goal is to secure office space for business growth.
In the company's terms
The price equals 52.42% of total assets (KRW 311.0 billion, end of 2025, consolidated). It is an estimate and will be settled at the final price after completion.
What changes for shareholders
Payment is split: a KRW 8.2 billion deposit on October 29, KRW 8.2 billion in October 2028 and KRW 16.3 billion in October 2031. The balance is due at closing. Ownership registration is expected on June 30, 2032.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
A